Role & responsibilities
CDMO Job Description: Manager / Sr. Manager / AGM Formulations Business Development
Position Summary:
We are looking for an experienced front end Business Development professional to come on-board and contribute to the expansion of Formulation CMO and CDMO business globally by identifying new opportunities and customers in both innovator and generics sectors.
Business Development and end-to-end Operations Management:
- Identification and generation of new Leads in NCE, 505(b) (2) and Generics segments and product / project evaluation of internal strategic fit
- Strong negotiation skills to convert Leads into Business and contribute and meet the assigned Annual Sales Target of Individual and Team
- Implementation of Travel plan to aggressively pursue new business meetings on-site and by attending networking conferences
- Generation of new business from existing customers
- Customer relationship management
- Coordination with R&D, PM, SCM, Manufacturing, QA, Finance and all other cross-functional teams
- Effective creation and submission of business costings and proposals against RFPs / RFQs
- Respond to RFIs on time
- Preparation of all promotional material for business development activities.
Requirement:
- Minimum 10-15 years of experience in front end and capable to travel independently and frequently, to generate revenues from year 1
- Bachelors or Masters degree in Business Administration, Life Sciences, Pharmacy, or a
related field
- In-depth knowledge on CMO / CDMO Market research and analysis
- Extended hours of work for customer approach by emails and cold-calling in local market time
- Excellent communication and negotiation abilities and ability to work under pressure and meet deadlines
Work Location: MSNs Corporate Office, Hyderabad
Keyskills: New Chemical Entity Business Development NCE Lead Generation Pharmaceutical
MSN Laboratories Pvt. Ltd MSN Group is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (APIs) and Finished dosages in India. Established in the year 2003, MSN Group comprises of eight API manufacturing plants ( including one for Oncology), two finished dosage facili...